Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel 1% vs Voltaren Gel in Knee OA
NCT02596451Phase 3Completed
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Aug 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in osteoarthritis (OA) (3 arms), sponsored by Glenmark Pharmaceuticals. Primary endpoint: Western Ontario and McMaster Universities Arthritis Index Pain Subscale Score at 4 weeks. Started Aug 2015; status: completed.
02
Drugs
diclofenac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02596451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596451.